Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans

International Journal of Medical Sciences

Volumn 8, Issue 3, 2011, Pages 192-197

  Seifert, John G ^a   Nelson, Aaron ^b   Devonish, Julia ^b   Burke, Edmund R ^c   Stohs, Sidney J ^d  

^a MONTANA STATE UNIVERSITY   (United States)

^b ST CLOUD STATE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bitter orange; Blood pressure; Caffeine; Citrus aurantium; Green tea; Heart rate; p Synephrine

Indexed keywords

ACCELERON; CAFFEINE; GREEN TEA EXTRACT; HERBACEOUS AGENT; OXEDRINE; PLACEBO; SOUR ORANGE EXTRACT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ACUTE DRUG ADMINISTRATION; ADULT; AIR ANALYSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXPIRED AIR; FEMALE; HEART RATE; HUMAN; MALE; OBESITY; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 79955529537     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.192     Document Type: Article

References (29)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. J Amer Med Assoc. 2010; 303(3): 235-241.
2. Lubitz CL, Flegal KM, Pamuk ER. The predicted effects of chronic obesity in middle age on medicare costs and mortality. Med Care. 2010; 48(6): 510-517.
3. Barkin SL, Heerman WJ, Warren MD, et al. Millennials and the world of work: the impact of obesity on health and productiv-ity. J Bus Psychol. 2010; 25(2): 239-245.
4. Preuss HG, DiFerdinando D, Bagchi M, et al. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. J Med. 2002; 33: 247-264.
5. Stohs SJ, Shara M. A review of the safety and efficacy of Citrus aurantium in weight management. In: Bagchi D and Preuss HG, editors. Obesity: epidemiology, pathophysiology, and preven-tion. Boca Raton (FL): CRC Press; 2007: 371-382.
6. Colker CM, Kalman DS, Torina GC, et al. Effects of Citrus au-rantium extract, caffeine and St. John's wort on body fat loss, lipid levels and mood states in normal weight and obese indi-viduals. Curr Therap Res. 1999; 60: 145-153.
7. Zenk JL, Leikam SA, Kassen LJ, et al. Effect of Lean System 7 on metabolic rate and body composition. Nutrition 2005; 21: 179-185.
8. Bent S, Padula A, Neuhaus J. Safety and efficacy of citrus au-rantium for weight loss. Am J Cardiol. 2004; 94:1359-1361.
9. Fugh-Berman A, Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med. 2004; 229:698-704.
10. Penzak SR, Jann MW, Cold JA, et al. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J Clin Pharmacol. 2001; 41:1059-1063.
11. Haller CA, Benowitz NL, Jacob IIIP. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 2005; 118:998-1003.
12. Stohs SJ, Preuss HG. The Safety of bitter orange (Citrus au-rantium) and its primary alkaloid p-synephrine. HerbalGram 2011; 89: 34-39.
13. Haller CA, Duan M, Peyton J III, et al. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. Brit J Clin Pharmacol. 2008; 65: 833-840.
14. Min B, Cios D, Kluger J, et al. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter orange extract in healthy subjects. Pharma-cotherapy. 2005; 25: 1719-1724.
15. Bui LT, Nguyen DT, Ambrose PJ. Blood pressure and heart rate effects following a single dose of bitter orange. Ann Pharma-codyn. 2006; 40: 53-57.
16. Gray S, Woolf AD. Citrus aurantium used for weight loss by an adolescent with anorexia nervosa. J Adol Hlth. 2005; 37: 415-416.
17. Thomas JE, Munir JA, McIntyre PZ, et al. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement. A case report and review of the literature. Texas Heart Inst J. 2009; 36: 586-590.
18. Stephensen TA, Sarlay Jr R. Ventricular fibrillation associated with use of synephrine containing dietary supplement. Military Med. 2009; 174:1313-1319.
19. Gougeon R, Harrigan K, Tremblay JF, et al. Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium. Obesity Res. 2005; 13: 1187-1194.
20. Sale C, Harris RC, Delves S, et al. Metabolic and physiological effects of ingesting extracts of bitter orange, green.tea and guarana at rest and during treadmill walking in overweight males. Int J Obesity 2006; 30: 764-773
21. Smedema JP, Muller GJ. Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine. So African Med J. 2008; 98: 372-373.
22. Sander LC, Putzbach K, Nelson BC, et al. Certification of standard reference materials containing bitter orange. Analyt Bioanalyt Chem. 2008; 391: 2023-2034.
23. Stewart A, Fernando R, McDonald S, et al. The dose-dependent effects of phenylephrine for elective cesarean delivery under spinal anesthesia. Anesth Analg. 2010 [epub ahead of print].
24. Inchiosa MA Jr. "Evidence (mostly negative) with the use of sympathomimetic agents for weight loss". J Obesity 2011 [epub ahead of print].
25. Arch JR. β-3-Adrenoreceptor agonists: potential, pitfalls and progress. Eur J Pharmacol. 2002; 440: 99-107.
26. Tsujita T, Takaku T. Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark). J Nutr Sci Vitaminol. 2007; 53: 547-551.
27. Carpene C, Galitzky J, Fontana E, et al. Selective activation of beta 3-adrenoreceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol. 1999; 359: 310-321.
28. Dews PB. Caffeine. Ann Rev Nutr. 1982; 2: 323-341.
29. Dews PB, O'Brien CP, Bergman J. Caffeine: behavioral effects of withdrawal and related issues. Food Chem Tox. 2003; 40: 1257-1261.